Zev A. Wainberg, MD, is a professor of medicine at the University of California, Los Angeles (UCLA) and co-director of the UCLA GI Oncology Program.
Experts Say FDA Approval of Perioperative Durvalumab Plus FLOT Sets New Standard of Care for Early-Stage Gastric, GEJ Cancers
As the first immunotherapy option in this setting, the approval sets a new standard for resectable early-stage gastric and gastroesophageal junction (GEJ) cancers.